NCT00967057View on ClinicalTrials.gov

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

January 31, 2010

Study Completion Date

December 31, 2011

Conditions
Leukemia
Interventions
DRUG

asparaginase

Given intramuscularly

DRUG

dexamethasone

Given orally

DRUG

idarubicin

Given IV

DRUG

methotrexate

Given intrathecally

DRUG

mitoxantrone hydrochloride

Given IV

DRUG

pegaspargase

Given intramuscularly

DRUG

vincristine sulfate

Given IV

Trial Locations (6)

5006

Women's and Children's Hospital, North Adelaide

B4 6NH

Birmingham Children's Hospital, Birmingham

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

WC1N 3JH

Great Ormond Street Hospital for Children, London

M20 4BX

Christie Hospital, Manchester

SO16 6YD

Southampton General Hospital, Southampton

All Listed Sponsors
lead

Children's Cancer and Leukaemia Group

OTHER

NCT00967057 - Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter